Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthrax Infection”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Early research (Phase 1)Study completedNCT04148118
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults

Who this might be right for
Anthrax
BlueWillow Biologics 84
Early research (Phase 1)Study completedNCT01952444
What this trial is testing

Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 40
Not applicableEnded earlyNCT03321903
What this trial is testing

EPR Tumor Oximetry With CE India Ink

Who this might be right for
Neoplasms, MalignantBreast NeoplasmCarcinoma, Basal Cell+4 more
Philip Schaner 3
Early research (Phase 1)Study completedNCT02934607
What this trial is testing

Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers

Who this might be right for
Study is Being Conducted in Healthy Volunteers
AstraZeneca 50
Testing effectiveness (Phase 2)Study completedNCT00100724
What this trial is testing

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

Who this might be right for
Anthrax
VaxGen 480
Early research (Phase 1)Study completedNCT03352466
What this trial is testing

NasoShield Study of Safety and Immunogenicity

Who this might be right for
Healthy Volunteers
Altimmune, Inc. 145
Early research (Phase 1)Study completedNCT00063843
What this trial is testing

Anthrax-rPA: Safety, Tolerability, Immunogenicity

Who this might be right for
Anthrax
National Institute of Allergy and Infectious Diseases (NIAID) 80
Early research (Phase 1)Study completedNCT01263691
What this trial is testing

Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults

Who this might be right for
Bacillus Anthracis (Anthrax) Infection
Emergent BioSolutions 105
Testing effectiveness (Phase 2)Study completedNCT01955382
What this trial is testing

Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria

Who this might be right for
MalariaSevere Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableUnknownNCT02483650
What this trial is testing

Hyperbaric Oxygen Therapy Registry

Who this might be right for
Air or Gas EmbolismCarbon Monoxide PoisoningClostridial Myositis and Myonecrosis (Gas Gangrene)+11 more
U.S. Wound Registry 5,000
Not applicableEnded earlyNCT05672875
What this trial is testing

Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System

Who this might be right for
Anthrax
SRI International 343
Testing effectiveness (Phase 2)Study completedNCT01794182
What this trial is testing

Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals

Who this might be right for
Ischemic StrokeMalignant Edema
Remedy Pharmaceuticals, Inc. 86
Testing effectiveness (Phase 2)WithdrawnNCT04928950
What this trial is testing

Charcoal in Lung Cancer Patients Undergoing TEMLA

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Study completedNCT00103467
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

Who this might be right for
Prevention of Anthrax Infection
VaxGen 100
Testing effectiveness (Phase 2)Study completedNCT01770743
What this trial is testing

Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

Who this might be right for
Anthrax
Emergent BioSolutions 168
Not applicableLooking for participantsNCT00050310
What this trial is testing

Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients

Who this might be right for
AnthraxBacillus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Early research (Phase 1)Study completedNCT04415749
What this trial is testing

NasoShield in Healthy Adults to Study Safety and Immunogenicity

Who this might be right for
Healthy Volunteers
Altimmune, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT03518125
What this trial is testing

BARDA Securing Anthrax Immunity For the Elderly

Who this might be right for
Anthrax
Biomedical Advanced Research and Development Authority 305
Not applicableStudy completedNCT03498027
What this trial is testing

Febrile Whole Blood Specimen Collection and Testing

Who this might be right for
Febrile InfectionAnthrax
MRI Global 97
Post-approval studies (Phase 4)Study completedNCT02339155
What this trial is testing

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

Who this might be right for
Infections, Bacterial
Emergent BioSolutions 573
Load More Results